ERES: ERESEARCHTECHNOLOGY INC Profile

Ticker

Advertisement

Choose a Broker

Dynamic view of the market

U.S. Markets open in 13 hrs, 29 mins

Symbol	Value	Change	Percentage Change
DJIA	11,288.54	73.03	0.65%
NASDAQ	2,245.38	-6.08	-0.27%
S&P 500	1,262.90	1.38	0.11%

ERESEARCHTECHNOLOGY INC

ERES

Stock price

16.62 -0.33 -1.95%

as of 01:00 PM EDT on 07/03/2008 in USD (NASDAQ Delay: 15 mins.)
Extended Hours

— — —

Analyst Consensus

Buy
Analyst Consensus

Strong Buy

Buy

Hold

Sell

Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: ERES

Insightful information about industries, companies, and the people who lead them.

Learn More.

2007 Sales	2007 Sales Growth	2007 Net Income	Employees
$86,800,000	0.6%	$15,400,000

Key Executives: ERES

Name	Title	Officer Since
Michael J. McKelvey, Ph.D.	CEO	7/25/06
Steven M. Eisenstein	CFO	-
Jeffrey S. Litwin, M.D.	Chief Medical Officer	-
Joel Morganroth, M.D.	Chief Scientific Officer	1/1/97
Thomas P. Devine	Executive VP	-
Dr. Gerald A. Faich, M.D., MPH	Director	1/1/04
Amy Furlong	Executive VP, Divisional	-
Richard A. Baron	—	-

View All Key Executives

Dr. Faich has served on our board of directors since 2004. Dr. Faich has served as Senior Vice President of UBC Epidemiology and Risk Management since June 2005. He served as the President of Pharmaceutical Safety Assessments, a consulting firm, from 1994 until June 2005. Dr. Faich co-chaired the original CIOMS International Adverse Reaction Working Group and was a founding board member of the International Society of Pharmacoepidemiology. Dr.... View Full Profile

Dr. Gerald A. Faich, M.D., MPH

Mr. Devine has been our Executive Vice President and Chief Development Officer since December 2005. Previously, he served as our Senior Vice President and Chief Development Officer from April 2003 until December 2005. From August 2002 to April 2003, Mr. Devine was our Vice President of Research and Development. Prior to joining us, Mr. Devine was Chief Technology Officer for ecHUB, Inc., an electronic commerce company, from January 2000 to July... View Full Profile

Thomas P. Devine

Ms. Furlong has been our Executive Vice President, Cardiac Safety since December 2005. She served as our Senior Vice President, Regulatory Compliance from January 2004 until December 2005. From February 2001 to January 2004, Ms. Furlong served as our Vice President, Regulatory Compliance.... View Full Profile

Amy Furlong

Ms. Furlong has been our Executive Vice President, Cardiac Safety since December 2005. She served as our Senior Vice President, Regulatory Compliance from January 2004 until December 2005. From February 2001 to January 2004, Ms. Furlong served as our Vice President, Regulatory Compliance.... View Full Profile

Richard A. Baron

Mr. Tiger has been our Senior Vice President, Americas Sales since October 2006. He served as our Senior Vice President, International Sales and Operations from October 2005 to September 2006, Senior Vice President, International Operations from July 2004 to October 2005, Vice President, International Business Development from August 2002 to July 2004 and as Director of Business Development from January 2001 to August 2002.... View Full Profile

George Tiger

Mr. Tiger has been our Senior Vice President, Americas Sales since October 2006. He served as our Senior Vice President, International Sales and Operations from October 2005 to September 2006, Senior Vice President, International Operations from July 2004 to October 2005, Vice President, International Business Development from August 2002 to July 2004 and as Director of Business Development from January 2001 to August 2002.... View Full Profile

John H. Park

Mr. Scheppmann has served on our board of directors since January 2006. Since September 2007, Mr. Scheppmann has served as Executive Vice President and Chief Financial Officer of Teradata Corporation, a data warehousing and enterprise analytics company. From May 2006 until September 2007, he served as Chief Financial Officer for Per-Se Technologies, Inc., a healthcare business services and information technology company and a wholly-owned... View Full Profile

Stephen M. Scheppmann

Dr. McKelvey has served as our President and Chief Executive Officer since June 2006 and has served on our board of directors since July 2006. Prior to joining us, Dr. McKelvey was employed by PAREXEL International, one of the largest biopharmaceutical outsourcing organizations in the world, for five years where he served as Corporate Senior Vice President, Clinical Research Services.... View Full Profile

Michael J. McKelvey, Ph.D.

Mr. Blakeley has been our Executive Vice President, Global Sales and Marketing since February 2008. He served as our Senior Vice President, International Operations and Sales from September 2006 to February 2008. He served as our Group Vice President, International Business Development from January 2005 to August 2006 and as our Director of Business Development from May 2002 to December 2004. Prior to joining eRT, Mr. Blakeley was Managing... View Full Profile

John M. Blakeley

Mr. Bonovitz has served on our board of directors since 1999. Mr. Bonovitz is Chairman Emeritus of and of counsel to Duane Morris LLP, having stepped down as Chairman and Chief Executive Officer in January 2008 after serving ten years in those positions. Mr. Bonovitz is also a director of Comcast Corporation. In addition, he serves on the advisory boards of several privately- held companies and he serves on the board of Trustees of The Curtis... View Full Profile

Sheldon M. Bonovitz

Dr. Litwin is a cardiologist and has been our Executive Vice President and Chief Medical Officer since December 2005. He served as our Senior Vice President and Chief Medical Officer from July 2000 until December 2005.... View Full Profile

Jeffrey S. Litwin, M.D.

Dr. Morganroth has been nominated by the Company's board of directors, with the recommendation of its governance and nominating committee, to serve as a member of the Company's board for a three-year term beginning in April 2008. Dr. Morganroth has served as the chairman of our board of directors since 1999 and a member of our board of directors since 1997. He has served as our Chief Scientific Officer since April 2006. Prior to that, he served... View Full Profile

Joel Morganroth, M.D.

Mr. Brown has been our Senior Vice President, Strategic Marketing, Planning & Partnerships since September 2006. He served as our Senior Vice President, Outsourcing Partnerships from July 2002 to August 2006. From January 2000 to June 2002, Mr. Brown was our Senior Vice President, Cardiac Safety.... View Full Profile

Robert S. Brown

Mr. Phillips has been nominated by the Company's board of directors, with the recommendation of its governance and nominating committee, to serve as a member of the Company's board for a three-year term beginning in April 2008. Mr. Phillips has served on our board of directors since August 2002. Mr. Phillips has served as Special Counsel to Medtronic, Inc. since 1999. Mr. Phillips was the Executive Vice President, General Counsel and Secretary of... View Full Profile

Stephen S. Phillips

Mr. Gathman has served on our board of directors since 2003. Since February 2008, Mr. Gathman has served as the Chief Financial Officer of SunGard Public Sector Group, Inc. a wholly-owned subsidiary of SunGard Data Systems, Inc. From May 2004 to January 2007, he served as Senior Vice President and Chief Financial Officer for SunGard Higher Education, Inc. Mr. Gathman provided consulting services for Targeted Diagnostics & Therapeutics, Inc. from... View Full Profile

David D. Gathman

Mr. Hitchner has served on our board of directors since 2004. Mr. Hitchner was a partner in the law firm of Pepper Hamilton LLP from May 1992 to June 1999, and returned to the firm in January 2001 as a partner and, subsequently, counsel through 2004. Commencing in 2005, Mr. Hitchner began providing consulting services to the firm. Mr. Hitchner is also a director of Mothers Work, Inc., for which he has served on the audit committee since 1993,... View Full Profile

Elam M. Hitchner

Effective on June 17, 2008, Steven M. Eisenstein, who is 44 and has been eRT"s Controller for seven years and a Vice President since May 2005, became the Company's interim Chief Financial Officer and Secretary, in addition to his prior position as Vice President and Corporate Controller.... View Full Profile

Steven M. Eisenstein

Mr. Laky has been our Senior Vice President, eClinical since February 2008. He served as our Vice President, Professional Services from October 1999 until February 2008.... View Full Profile

David Laky

Mr. Sadowski has been our Senior Vice President, ePRO since February 2008. He is also the director of our Information Technology and Customer Care groups. He served as our Vice President and General Manager, ePRO since the group's inception in June 2007. He previously served as our Vice President, Information Technology, Customer Care and Logistics from December 2005 to May 2007 and our Vice President, Information Technology and Customer Care... View Full Profile

Gregory Sadowski

Top Competitors: ERES

View Detailed Competitors Chart

Insider Trends: ERES
Sentiment for ERES is NEGATIVE
- 0M
- 2M
- 4M
- 6M
- Market Value of Insider Sales
- Market Value of Insider Purchases
Total dollar value of all insider purchases and sales over 12 months
View All Insider Sentiment

Insider Transactions: ERES

Date	Name	Shares	Transaction Type	Market Value
06/25/08	PHILLIPS STEPHEN S	1,140	Stock Gift	$0.00
06/12/08	LITWIN JEFFREY S	10,000	Sale	$160,063.16
05/19/08	JEFFREY LITWIN TRUST	20,000	Planned Sale	$319,000.00

View All Insider Activity

Ownership Breakdown : ERES

Large Block Holder Type	Number
Institutions	152.00
Mutual Fund	195.00
Other Major	9.00

Full Details

Indices : ERES

Symbol	Name	Last Trade	Change
$RUT.X	Russell 2000 Index	—	——%

View all Indices that include ERES

Short Interest Volume: ERES

Data as of 6/10/08

Current Short Interest Shares	1.10 B
Current Short Interest Ratio	8.50
Float	48.40 M

Short Interest as % of Float	8.50
Average Daily Volume	611,000.00
Outstanding Shares	50.67 M

Full Details

SEC Filings: ERES

Accepted Date	Description
06/26/2008	SEC Filing: Insider Buy/Sell
06/18/2008	SEC Filing: New Insider Report
06/18/2008	SEC Filing: Current Event

View all SEC Filings

Get Profile Details for:

- Help & Feedback

Market Movers

Related Resources

My Portfolios

AOL Real-Time Streaming Quotes

ERESEARCHTECHNOLOGY INC

ERES

Stock price

16.62 -0.33 -1.95%

as of 01:00 PM EDT on 07/03/2008 in USD (NASDAQ Delay: 15 mins.)
Analyst Consensus
- Strong Buy
- Buy
- Hold
- Sell
- Strong Sell
- Add to Portfolio
- Add to Alerts
Discuss: ERES

Quote Search Search the Web Search

More in Money & Finance
- Money
- Earnings
- Tech News
- Stock Screener
- Banking
- Checking Account
- Savings Account
- Credit Cards
- Credit Reports
- Identity Theft
- Debt Management
- Loans
- Auto Loan
- Personal Loans
- Mortgages
- Refinancing
- Taxes
- Online Tax Filing
- Tax Advice
- Tax Basics
- Tax Forms
- Audit
- Tax Credit
- Tax Deduction
- AMT
- Small Business
- BloggingStocks
- BloggingBuyouts
- Luxist
- TUAW
- DJIA
- Dow Jones Industrial Average
More Stock Research
Notices and Terms: Confirm all data with your broker before trading.

Quote data provided by Interactive Data. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Financial.

The ERESEARCHTECHNOLOGY INC profile at AOL Money & Finance provides you with all the eres investing information you need. Reference AOL Money & Finance before you make your next investment!

© 2008 AOL LLC. All Rights Reserved.

AOL@Money © 2008 AOL LLC. All Rights Reserved.

Live Updates:

Ticker

Dynamic view of the market

ERESEARCHTECHNOLOGY INC

ERES

Stock price

Extended Hours

Analyst Consensus

ERESEARCHTECHNOLOGY INC Profile

Key Executives: ERES

Top Competitors: ERES

Insider Trends: ERES

Insider Transactions: ERES

Ownership Breakdown : ERES

Indices : ERES

Short Interest Volume: ERES

SEC Filings: ERES

Quote Details

Classic Chart

Advanced Chart BETA

Real-Time Headlines

Message Boards

Profile

Earnings Analysis

Event Calendar

Financials